Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:809014.
doi: 10.1155/2015/809014. Epub 2015 Nov 4.

General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection

Affiliations
Review

General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection

Sonia Faria et al. J Pathog. 2015.

Abstract

Nontuberculous mycobacteria (NTM) are emergent pathogens whose importance in human health has been growing. After being regarded mainly as etiological agents of opportunist infections in HIV patients, they have also been recognized as etiological agents of several infections on immune-competent individuals and healthcare-associated infections. The environmental nature of NTM and their ability to assemble biofilms on different surfaces play a key role in their pathogenesis. Here, we review the clinical manifestations attributed to NTM giving particular importance to the role played by biofilm assembly.

PubMed Disclaimer

Figures

Figure 1
Figure 1
NTM persist in a steady state between planktonic (a) and biofilm (b) within healthcare units and on medical devices. Biofilm assembly is triggered by environmental stress. Bacteria organized in biofilm exhibit a different structure being notorious, increasing the amount of extracellular matrix (red arrows). Another feature of these bacteria is the increased resistance to chemical sterilization, which leads to persistence within healthcare units, host colonization, and onset of disease. (Red circles: dead bacteria; green circles: live bacteria; scale bar 1 μm.)

References

    1. Primm T. P., Lucero C. A., Falkinham J. O., III Health impacts of environmental mycobacteria. Clinical Microbiology Reviews. 2004;17(1):98–106. doi: 10.1128/cmr.17.1.98-106.2004. - DOI - PMC - PubMed
    1. Tsuyuguchi K., Suzuki K., Sakatani M. Epidemiology of infection by nontuberculous mycobacteria. Respiration and Circulation. 2004;52(6):561–564.
    1. Falkinham J. O., III Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. Journal of Applied Microbiology. 2009;107(2):356–367. doi: 10.1111/j.1365-2672.2009.04161.x. - DOI - PubMed
    1. Hoefsloot W., Van Ingen J., Andrejak C., et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. European Respiratory Journal. 2013;42(6):1604–1613. doi: 10.1183/09031936.00149212. - DOI - PubMed
    1. Griffith D. E., Aksamit T., Brown-Elliott B. A., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine. 2007;175(4):367–416. doi: 10.1164/rccm.200604-571st. - DOI - PubMed